Lack of specificity (e.g., uptake in other benign or malignant lesions) for PCa associated with fluciclovine and PSMA PET may result in false-positive lesions, highlighting the importance of a concurrent diagnostic CT scan [26, 80]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.